✦ LIBER ✦

36 Plasminogen activator inhibitor type-1 inhibits integrin- and vitronectin-dependent cell migration

✍ Scribed by L. Kjøller; S.M. Kanse; T. Kirkegaard; K.W. Rodenburg; E. Rønne; S.L. Goodman; K.T. Preissner; L. Ossowski; P.A. Andreasen

Book ID: 117439413
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 134 KB
Volume: 11
Category: Article
ISSN: 0268-9499
DOI: 10.1016/s0268-9499(97)80151-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Plasminogen Activator Inhibitor-1 Repres

Plasminogen Activator Inhibitor-1 Represses Integrin- and Vitronectin-Mediated Cell Migration Independently of Its Function as an Inhibitor of Plasminogen Activation

✍ Lars Kjøller; Sandip M. Kanse; Tove Kirkegaard; Kees W. Rodenburg; Ebbe Rønne; S 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 254 KB

Interactions between type 1 plasminogen

Interactions between type 1 plasminogen activator inhibitor, extracellular matrix and vitronectin

✍ D. Seiffert; J. Mimuro; R.R. Schleef; D.J. Loskutoff 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 702 KB

Kinetic analysis of integrin-dependent c

Kinetic analysis of integrin-dependent cell adhesion on vitronectin : The inhibitory potential of plasminogen activator inhibitor-1 and RGD peptides

✍ Matthias Germer; Sandip M. Kanse; Tove Kirkegaard; Lars Kjøller; Brunhilde Feldi 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB

Endothelial cell overexpression of plasm

Endothelial cell overexpression of plasminogen activator inhibitor - 1 (PAI-1) inhibits smooth muscle cell migration

✍ Richard R Proia; Peter R Nelson; Mary-Jo Mulligan-Kehoe; Arthur J Kehas; Robert 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 249 KB

Plasminogen activator inhibitor type 1 i

Plasminogen activator inhibitor type 1 inhibits smooth muscle cell proliferation in pulmonary arterial hypertension

✍ Fotini M. Kouri; Markus A. Queisser; Melanie Königshoff; Izabella Chrobak; Klaus 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 841 KB

TYPE-1 PLASMINOGEN ACTIVATOR INHIBITOR I

TYPE-1 PLASMINOGEN ACTIVATOR INHIBITOR IN HUMAN RENAL CELL CARCINOMA

✍ WAGNER, STEPHAN N.; ATKINSON, MICHAEL J.; THANNER, STEPHANIE; SCHMITT, MANFRED; 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 597 KB

In experimental models, plasminogen activator-mediated degradation of the extracellular matrix is inhibited by type-1 plasminogen activator inhibitor (PAI-1). PA14 has also been shown to protect tumour stromal tissue from autoproteolytic activities and may thus substantially promote tumour growth an